View of PHARMACOECONOMIC BURDEN AND COST-REDUCTION IMPACT OF PHARMACIST-LED BRAND SUBSTITUTION IN HYPERTENSION MANAGEMENT: A CROSS-SECTIONAL STUDY FROM PAKISTAN | Frontier in Medical and Health Research

Frontier in Medical & Health Research

← PHARMACOECONOMIC BURDEN AND COST-REDUCTION IMPACT OF PHARMACIST-LED BRAND SUBSTITUTION IN HYPERTENSION MANAGEMENT: A CROSS-SECTIONAL STUDY FROM PAKISTAN